Sign In
Buy IGC
$0.300
+0.0100 (+3.45%)
At Close: Jun 03, 2026
IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer's Patients
11:26pm, Monday, 07'th Jun 2021
POTOMAC, Md.--(BUSINESS WIRE)-- #AD--IGC Completes Cohort 2 of its Phase 1 Tetrahydrocannabinol (“THC”)-Based Investigational New Drug Clinical Trial on Alzheimer's Patients.
India Globalization Capital (IGC) Completes Cohort 1 of its Phase 1 THC-Based Clinical Trial on Alzheimer's Patients
06:01am, Friday, 14'th May 2021
POTOMAC, Md.--(BUSINESS WIRE)-- #AD--IGC Completes Cohort 1 of its Phase 1 THC-Based Clinical Trial on Alzheimer's Patients
IGC Receives Another Patent for a Cannabinoid-Based Cream for Treating Pain
06:33pm, Monday, 08'th Mar 2021
POTOMAC, Md.--(BUSINESS WIRE)-- #AD--IGC got patent (#10,933,082) x its cannabinoid composition & method x treating pain due to Psoriatic Arthritis, Fibromyalgia, Scleroderma & others.
Cannabis Earnings: India Globalization Capital Reports Q3 Results
03:27am, Wednesday, 17'th Feb 2021
The bullish conditions over cannabis stocks remain, although momentum has slowed down. International Globalization Capital works in two different sectors, Materials and Health Care (cannabis).
IGC Commences Phase 1 of Cannabinoid Clinical Trial for Alzheimer's Patients
09:00am, Monday, 23'rd Nov 2020
POTOMAC, MD--(BUSINESS WIRE)-- #AD--India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) announced that it is enrolling participants suffering from mild to severe de
POTOMAC, Md.--(BUSINESS WIRE)-- #AD--India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) today announced its financial results for the quarter ended September 30, 2
IGC Reports Financial Results for June 30, 2020 Quarter and Prepares for Phase 1 Cannabinoid Clinical Trial for Alzheimer’s Patients in Puerto Rico.
IGC's stock rallies again, after rocketing fourfold on record volume in the previous session
11:36am, Thursday, 13'th Aug 2020
Shares of India Globalization Capital Inc. surged 26% in premarket trading Thursday, to extend the fourfold rocket ride in the previous session, as they head for an open at the highest level seen dur
India Globalization Surges On CBD Trial For Alzheimer's
01:40pm, Wednesday, 12'th Aug 2020
India Globalization Capital, Inc. (NYSE: IGC) shares are advancing strongly after the company unveiled plans to start an early-stage clinical trial for its cannabinoid, or CBD, formulation.What Happen
FDA Approves Initiation of IGC’s Cannabinoid Trial on Alzheimer’s Patients
09:03pm, Tuesday, 11'th Aug 2020
FDA Approves Initiation of IGC’s Cannabinoid Trial on Alzheimer’s Patients.
FDA Approves Initiation of IGC’s Cannabinoid Trial on Alzheimer’s Patients
12:00am, Tuesday, 11'th Aug 2020
FDA Approves Initiation of IGC’s Cannabinoid Trial on Alzheimer’s Patients.
52 Stocks Moving In Wednesday's Regular-Market Session
12:00am, Wednesday, 29'th Jul 2020
Gainers
Eastman Kodak (NYSE: KODK) shares rose 430.46% to $42.49 during Wednesday's regular session. The market value of their outstanding shares is at $1.8 billion.
Civeo (...
IGC Filed a Patent Application with the U.S. Patent Office for a New Formulation to Treat Pain
11:00am, Tuesday, 21'st Jul 2020
IGC filed a patent application with the USPTO for a new cannabinoid formulation intended for treatment of pain in humans and veterinary animals.
IGC Receives a Notice of Allowance from the U.S. Patent Office
11:00am, Monday, 20'th Jul 2020
IGC received Notice of Allowance from United States Patent & Trademark Office for its cannabinoid formulation to treat seizures in humans & animals.
IGC Receives a Notice of Allowance from the U.S. Patent Office
12:00am, Monday, 20'th Jul 2020
IGC received Notice of Allowance from United States Patent & Trademark Office for its cannabinoid formulation to treat seizures in humans & animals.
